Literature DB >> 33771974

Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early.

Sonia N Wolf1, Jana Haddow2, Claire Greiller1, Graham P Taylor1,2, Lucy B M Cook1,2,3, Aileen G Rowan4,5.   

Abstract

Adult T cell leukaemia/lymphoma (ATL) arises from clonally expanded T cells that are infected with human T cell leukaemia virus type-1 (HTLV-1). Here, we show that ATL can be detected early in HTLV-1-carriers through quantification of T-cell receptor (TCR)Vβ subunit diversity on T-cells infected with HTLV-1 (CD3+ CCR4+ CD26- T-cells) using an 'oligoclonality index' (OCI-flow). We established a reference range for OCI-flow by analysing peripheral blood mononuclear cells (PBMCs) from HTLV-1-carriers who had not developed ATL in a median of 10.5 years follow up (n = 38) and patients with ATL (n = 30). In the third cohort of HTLV-1-carriers with no history or clinical evidence of ATL (n = 106), 19% of high proviral load (PVL, ≥4 copies of HTLV-1/100 PBMCs) carriers had an OCI-flow in the ATL range, >0.770. Carriers with an OCI-flow >0.770 (n = 14) had higher lymphocyte counts and PVLs and were more likely to have a family history of ATL than carriers with OCI-flow ≤0.770. ATL subsequently developed in two of these 14 carriers but no carriers with OCI-flow ≤0.770 (p = 0.03, cumulative follow-up 129 person-years). This method can be used to identify a subset of high-PVL HTLV-1-carriers at increased risk of developing ATL who may benefit from intervention therapy, prior to the detection of disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33771974      PMCID: PMC7997885          DOI: 10.1038/s41408-021-00458-8

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN: 2044-5385            Impact factor:   11.037


  26 in total

1.  Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study.

Authors:  Yoshitaka Imaizumi; Masako Iwanaga; Kunihiro Tsukasaki; Tomoko Hata; Masao Tomonaga; Shuichi Ikeda
Journal:  Blood       Date:  2005-01-15       Impact factor: 22.113

2.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

3.  Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma.

Authors:  Andrew Hodson; Daniel J Laydon; Barbara J Bain; Paul A Fields; Graham P Taylor
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

4.  The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Authors:  Nicolas A Gillet; Nirav Malani; Anat Melamed; Niall Gormley; Richard Carter; David Bentley; Charles Berry; Frederic D Bushman; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

5.  CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.

Authors:  Seiichiro Kobayashi; Kazumi Nakano; Eri Watanabe; Tomohiro Ishigaki; Nobuhiro Ohno; Koichiro Yuji; Naoki Oyaizu; Satomi Asanuma; Makoto Yamagishi; Tadanori Yamochi; Nobukazu Watanabe; Arinobu Tojo; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Clin Cancer Res       Date:  2014-04-11       Impact factor: 12.531

6.  HTLV-1-infected T cells contain a single integrated provirus in natural infection.

Authors:  Lucy B Cook; Aileen G Rowan; Anat Melamed; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

7.  Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis.

Authors:  Aileen G Rowan; Richard Dillon; Aviva Witkover; Anat Melamed; Maria-Antonietta Demontis; Nicolas A Gillet; Liew Jun Mun; Charles R M Bangham; Lucy B Cook; Paul A Fields; Graham P Taylor
Journal:  Blood       Date:  2020-06-04       Impact factor: 22.113

8.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

9.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

10.  Quantification of HTLV-1 clonality and TCR diversity.

Authors:  Daniel J Laydon; Anat Melamed; Aaron Sim; Nicolas A Gillet; Kathleen Sim; Sam Darko; J Simon Kroll; Daniel C Douek; David A Price; Charles R M Bangham; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2014-06-19       Impact factor: 4.475

View more
  2 in total

1.  Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro.

Authors:  Bethany S Schneiderman; Michal S Barski; Goedele N Maertens
Journal:  Front Med (Lausanne)       Date:  2022-04-25

2.  Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.

Authors:  Ayumu Ito; Nobuaki Nakano; Takashi Tanaka; Shigeo Fuji; Junya Makiyama; Yoshitaka Inoue; Ilseung Choi; Hirohisa Nakamae; Koji Nagafuji; Ken Takase; Shinichiro Machida; Tsutomu Takahashi; Yasushi Sawayama; Tomohiko Kamimura; Koji Kato; Toshiro Kawakita; Masao Ogata; Rika Sakai; Souichi Shiratori; Kaoru Uchimaru; Yoshihiro Inamoto; Atae Utsunomiya; Takahiro Fukuda
Journal:  Blood Adv       Date:  2021-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.